Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Agilent technologies - What They Never Told You

Agilent Technologies Stock: Analyst Estimates & Ratings

While Agilent stock has underperformed the broader market over the past year, analysts remain moderately bullish about its prospects.

Barchart

How Is Agilent Technologies' Stock Performance Compared to Other Healthcare Stocks?

Despite Agilent Technologies’ underperformance relative to its industry peers, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like Agilent Technologies Stock?

While Agilent Technologies has underperformed the broader market over the past year, it has outpaced the healthcare sector, and analysts remain optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Agilent Technologies’ Quarterly Earnings Preview: What You Need to Know

Agilent Technologies is expected to release its fiscal fourth-quarter earnings soon, and analysts project a high single-digit earnings rise.

Barchart

Agilent Technologies Stock: Is A Underperforming the Healthcare Sector?

Despite Agilent Technologies’ underperformance relative to the healthcare sector, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Nasdaq Futures Tread Water With Nvidia Earnings in Focus

September Nasdaq 100 E-Mini futures (NQU25) are trending up +0.02% this morning, with investors in wait-and-see mode ahead of a highly anticipated earnings report from AI darling Nvidia.

Barchart

Agilent Technologies' Q3 2025 Earnings: What to Expect

Agilent Technologies is expected to release its fiscal third-quarter earnings later next month, and analysts project a single-digit profit growth.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is Agilent Technologies Stock Underperforming the Dow?

While Agilent Technologies has lagged behind the Dow recently, analysts remain moderately optimistic about the stock’s prospects.

Barchart

Is Agilent Technologies Stock Underperforming the S&P 500?

Despite Agilent Technologies’ recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Expert Outlook: Agilent Technologies Through The Eyes Of 4 Analysts

Throughout the last three months, 4 analysts have evaluated Agilent Technologies (NYSE:A), offering a diverse set of opinions from bullish to bearish.

Benzinga

How Is Agilent Technologies’ Stock Performance Compared to Healthcare Stocks?

Agilent Technologies has underperformed the healthcare sector lately, and analysts are moderately optimistic about the stock’s potential.

Barchart

What Are Wall Street Analysts' Target Price for Agilent Technologies Stock?

As Agilent Technologies underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

What to Expect From Agilent Technologies' Q3 2024 Earnings Report

Agilent Technologies is poised to release its third-quarter results next month, and analysts are projecting a single-digit earnings decline.

Barchart

3 Medical Stocks Set to Soar in 2024

The healthcare industry in 2024 is shaped by personalized medicine and innovative technologies in pharmacy, diagnostic testing, and medical devices. Hence, fundamentally strong medical stocks CVS Health (CVS), Agilent Technologies (A), and MiMedx Group (MDXG) could garner significant gains in the upcoming year. Read more….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Uncovering the Investment Prospects of Agilent Technologies (A) and Medtronic (MDT)

The medical industry is poised for growth with technological advancements, increasing disease rates, and government support. Therefore, let's assess the investment prospects of leading medical stocks Agilent Technologies (A) and Medtronic (MDT). Read more….

Barchart

Building Wealth with Spinoffs: How Adding These Gems Can Transform Your Portfolio

Spinoffs are value creating investment opportunities. You should be looking at them

Bangkok Post

Agilent empowers Thailand’s research frontier

Agilent Technologies, a global laboratory technology provider, is driving growth in the Thai market where research investment is burgeoning through the support of new advanced technologies and collaboration with local partners.

Benzinga

Agilent Technologies Whale Trades Spotted

Someone with a lot of money to spend has taken a bullish stance on Agilent Technologies (NYSE:A). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022

Benzinga

Here's How Much $100 Invested In Agilent Technologies 5 Years Ago Would Be Worth Today

Agilent Technologies (NYSE:A) has outperformed the market over the past 5 years by 5.5% on an annualized basis producing an average annual return of 15.19%. Currently, Agilent Technologies has a market capitalization of $35.66 billion.

StockNews.com

Agilent Technologies Down Almost 30% In 2022, Is Now Time To Buy?

Shares of the medical diagnostics and research company Agilent Technologies (A) have plunged nearly 30% year-to-date. However, Wall Street analysts see significant upside potential in the stock, given its solid fundamentals. So, is the stock a buy now? Read on to find out.

Benzinga

How Is The Market Feeling About Agilent Technologies?

Agilent Technologies's (NYSE:A) short percent of float has fallen 32.77% since its last report. The company recently reported that it has 3.55 million shares sold short, which is 1.19% of all regular shares that are available for trading.

Benzinga

Here's How Much $100 Invested In Agilent Technologies 10 Years Ago Would Be Worth Today

Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 4.24% on an annualized basis producing an average annual return of 16.21%. Currently, Agilent Technologies has a market capitalization of $37.86 billion.

Benzinga

$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much

Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 3.86% on an annualized basis producing an average annual return of 15.33%. Currently, Agilent Technologies has a market capitalization of $37.67 billion.

Benzinga

Agilent Technologies's Earnings: A Preview

Agilent Technologies (NYSE:A) is set to give its latest quarterly earnings report on Tuesday, 2022-05-24. Here's what investors need to know before the announcement. Analysts estimate that Agilent Technologies will report an earnings per share (EPS) of $1.07.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.